Acadia Pharmaceuticals Inc. (ACAD) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for ACAD. 13F holdings as of 2026-06-30.
In 13F filings for the quarter ended June 30, 2026, 342 institutions reported holding ACAD, with 168.5 million shares worth $4.3 billion in aggregate.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| Baker Bros. Advisors | 42,912,904 | $1.1B | INCREASED |
| BlackRock | 22,515,173 | $570M | INCREASED |
| Vanguard | 15,728,917 | $398M | INCREASED |
| State Street | 9,076,212 | $230M | INCREASED |
| Rtw Investments | 7,144,524 | $181M | UNCHANGED |
Recent Insider Trades
| Insider | Type | Shares | Value | Date |
|---|---|---|---|---|
| Mark C. Schneyer (EVP, CHIEF FINANCIAL OFFICER) | SELL | 3,321 | $69K | 2026-10-30 |
| Mark C. Schneyer (EVP, CHIEF FINANCIAL OFFICER) | AWARD | 6,815 | 2026-10-15 |
Full institutional holdings, insider history, and congressional trades for Acadia Pharmaceuticals Inc. on SentiSense.